Molecular Tumor Board - Metastatic melanoma with CDKN2A and PD-L1

Dr. Paul Walker conducts a virtual Molecular Tumor Board. The subject is a Molecular Tumor Board - Metastatic melanoma with a normal LDH. Remarkable markers include CDKN2A and PD-L1.
Dr. Walker discusses the treatment and supporting studies for his assessment.